Remarkably, the latest study reveals that artesunate, an FDA-approved anti-malaria drug, prevents the development of A pathology in mice by elevating PICALM expression in BECs, suggesting a promising translation to human AD (Kisler et al., 2023)
peripherally, they improve glycemic control by enhancing insulin secretion, reducing glucagon, delaying gastric emptying, and regulating gut hormones
Personalized GLP-1 Therapy: Genetic Testing Optimizes Treatment Selection The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
3 , (200ml) , , ,
GLP-1 maintenance is typically reserved for patients who have already undergone transformative weight loss